How Elon Musk's Online Pharmacy Inquiry Led Mark Cuban to Deliver Affordable Medications

When Elon Musk posed a straightforward question about drug pricing on the X platform, Mark Cuban saw an opportunity to demonstrate the transformative power of his online pharmacy model. The exchange between the tech billionaire and the Dallas-based entrepreneur highlighted a fundamental problem in the pharmaceutical industry: the astronomical markups between what medications cost in different parts of the world.

The $0.02 Question: Exposing the Pharmaceutical Pricing Gap

Back in June, a user challenged Mark Cuban’s Cost Plus Drugs platform over its limited medication offerings, specifically asking why the online pharmacy didn’t stock ivermectin. The inquiry pointed to a striking disparity: the anti-parasitic treatment costs just $0.02 per pill in Africa, yet Americans pay approximately 100 times that amount. Elon Musk, who was monitoring the conversation, added his voice with a simple acknowledgment: “Good question.”

Cuban explained at the time that his team couldn’t secure better pricing from suppliers than other available sources, though he offered Hydroxychloroquine as an alternative through his online pharmacy platform. He also extended a broader invitation, suggesting that Musk have his employees leverage Cost Plus Drugs to unlock significant savings on prescription medications.

Cost Plus Drugs Delivers: From Query to Solution

Approximately six months later, in December 2023, Cuban circled back to Musk with exciting news. Cost Plus Drugs had successfully sourced ivermectin and made it available through the online pharmacy. Cuban’s message was direct: the platform could now deliver the medication Musk had inquired about, and emphasized the potential cost benefits for his entire ecosystem of companies.

The numbers tell a compelling story. On Cost Plus Drugs, customers can purchase ivermectin for $91.40 per 30-tablet pack—roughly $3.04 per pill. Compare this to traditional channels: WebMDRx lists the branded version (Stromectol) at $188.44 for 30 tablets ($6.28 per pill), with discounted pricing bringing it down to $106.85. The online pharmacy’s pricing represents a dramatic reduction, demonstrating how eliminating middlemen through a transparent cost-plus model fundamentally reshapes drug affordability.

Scaling Impact: Enterprise Savings Through Online Pharmacy Innovation

Cuban indicated that tens of thousands of X users have already benefited from the platform’s aggressive pricing strategy. For major enterprises like Tesla, SpaceX, and X, an online pharmacy that can deliver such substantial cost reductions presents a meaningful opportunity to lower employee healthcare expenses. The invitation remained open: all that was needed was for someone from Musk’s organization to reach out and explore the partnership.

The broader conversation reflects growing public frustration with pharmaceutical companies’ pricing practices and their influence over legislation aimed at controlling prescription drug costs. Mark Cuban’s online pharmacy represents a direct challenge to that system—proving that when middlemen are removed and pricing becomes transparent, medications become genuinely affordable. Whether Musk’s companies will capitalize on this opportunity remains to be seen, but the conversation itself underscores how entrepreneurial innovation in healthcare can disrupt entrenched industry practices.